IL33 and metabolic disease: Since prediabetes is an early-stage metabolic disorder which, if left unmanaged, often progresses to T2D, one would have expected to observe a similar dynamic between IL-33/ST2 and HbA1c among individuals with prediabetes and T2D; however, this was not the case.